3D Printing for saving humanity

$20 Million in a Series A Funding for 3D Bioprinting of Human Tissue

Posted on Updated on

According to Sam Davies, “We are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”

According to Tamer Mohamed, CEO, Aspect Biosystems, “We are thrilled to close this important institutional financing round with a group of world-class investors who believe in our bold vision. This funding speaks to the power of our technology and strategy in addressing multiple applications in therapeutic discovery and regenerative medicine, and will allow us to accelerate internal innovation and expand our global partnerships. With our technology platform, interdisciplinary team of scientists and engineers, and leading collaborators, we are developing a new wave of solutions that have the potential to transform how we heal injury and disease.”

According to Jordan Jacobs, managing partner, Radical Ventures, “We are very excited to partner with the excellent Aspect team to support the growth of their world-leading 3D bioprinting platform and the development of breakthrough technologies aimed at radically transforming human health.

 

Aspect Biosystems raises $20m in Series A funding

Aspect Biosystems

ASPECT BIOSYSTEMS ANNOUNCES US $20 MILLION SERIES A FINANCING TO ADVANCE ITS LEADING PLATFORM FOR 3D BIOPRINTING OF HUMAN TISSUE

Advertisements

Dinsmore custom footwear for the child

Posted on Updated on

Dinsmore Inc. was founded by Jay Dinsmore, a winner of the 2019 Distinguished Innovator Operators Award (DINO) and an outspoken advocate and educator for Additive Manufacturing and 3D Printing technologies.
As mentioned above about Dinsmore team,” the team design the CAD model and shape of each 3D printed midsole to fit the specific TEVA and UGG shoes that they were bonded to custom, 3D printed orthotics for Imre Patterson, a young boy who was born with a femoral discrepancy (causing one leg to be shorter than the other). Using breakthroughs in both 3D printing technology and materials designed an alternative to his traditional manufactured foam boot using Carbon’s Digital Light Synthesis™ (DLS) technology to 3D print a lightweight, latticed midsole. This is the same technology used to manufacture the midsoles of Adidas 4D Futurecraft shoes.”

 

 

Dinsmore

Irvine 3D Printing Company Dinsmore Inc. Helps Fast Track Custom Footwear for Child in Need

3D Printing Resin for Night Guards and Splints

Posted on Updated on

KeySplint Soft™ Clear by Keystone Industries®, a Unique 3D Printing Resin for Night Guards and Splints Available Exclusively on the Carbon® Digital Manufacturing Platform, Cleared for Sale by U.S. FDA. According to Keystone Industries, “They developed industry-leading products like Diamond D® high-impact denture base, the Pro-Form® line of thermoplastics, innovative and patent-protected laboratory offerings, such as Enamelite ceramic spray glazes and the winner of Dental Advisor’s top product of the year, our Gelato prophy paste. Keystone has spent nearly three decades formulating and producing biocompatible, cutting-edge, patented photopolymer resins for dental and cosmetic nail applications. Keystone maintains FDA licensing, ISO 13485 (medical device) and 22716 certifications, along with GMP certification and international product registrations.”

KeySplint Soft™ Clear by Keystone Industries®, a Unique 3D Printing Resin for Night Guards and Splints Available Exclusively on the Carbon® Digital Manufacturing Platform, Cleared for Sale by U.S. FDA

Keystone Industries

3D Printed Digital Denture

Posted on Updated on

According to Dentsply Sirona and Carbon,” are pleased to present a ground-breaking, 3D printed workflow that provides significant advancements in terms of material benefits, the laboratory process, and function for the patient. From reduced chair time to improved comfort + fit, digital dentistry is transforming patient experiences. Learn how Affordable Care and Core 3D are utilizing the Carbon platform to revolutionize the dental industry as we know it.”

Taking Digital Dentistry to the Next Level

3D-printed bunny contains DNA

Posted on Updated on

According to the teams of Robert Grass at the Swiss Federal Institute of Technology in Zurich and Yaniv Erlich at Erlich Lab, a DNA storage company in Israel, “One day he [Erlich] wrote an email – ‘Hey, what if we put real information into your object? That would be really cool,’” 3D-printed bunny contains DNA instructions to make a copy of itself. Using the information, researchers have replicated the rabbit several times, highlighting the potential for using DNA to store information in everyday objects.”

This Plastic Bunny is Filled With Artificial DNA. The Data Inside: More Bunnies

3D-printed bunny contains DNA instructions to make a copy of itself Read more

A DNA-of-things storage architecture to create materials with embedded memory

BRECA Health Care

Posted on Updated on

According to BRECA Health Care,” is a biomedical engineering company that uses 3D printing technologies, computer aided design, reverse engineering and computational validation in order to develop state of the art custom made products and solutions in the healthcare sector. We are pioneers in the development of 3D bioprinting systems that are fundamental for the community of research in the development of new pharmaceuticals and advanced therapies. We are proud to say that we are helping to shape the future of medicine.”

BRECA Health Care

TRILUMINATE Pivotal Study for Abbott’s TriClip device

Posted on Updated on

According to Professor Georg Nickenig, lead investigator of the study and chair of Internal Medicine and Polyclinic II at the University of Bonn, Germany, presented findings. Data show a TR reduction of at least one grade in 87 percent of patients with symptomatic or greater TR and improvements in quality-of-life, “The TriClip is a version of the MitraClip used for transcatheter mitral valve repair (TMVR) to resolve mitral regurgitation. A post hoc registry analysis of MitraClip use for TR has indicated TR reduction and improved clinical outcomes out to one year. Treatment for TR is currently limited to the use of diuretics and high-risk surgical procedures. Nickenig said minimally invasive catheter-based procedures (such as TriClip) may reduce TR with low procedural risk.”

 

TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study

3D Printing For Cardiology

Posted on Updated on

According to Dee Dee Wang, M.D., director, structural heart imaging at Henry Ford Hospital, Detroit,” explains how her center uses 3-D printing and computer-aided design (CAD) software to improve patient outcomes. She spoke to DAIC at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. ‘The Use of 3-D Printing in Cardiology’ and “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”

According to Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple of trends he sees in cardiac nuclear imaging. He is the Vered Chair and division head of cardiology and director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada. He said,” overall trends he sees in nuclear cardiology include the use of better myocardial reserve quantification so it is clear whether revascularization would help patients. Beanlands also said there is increasing interest in positron emission tomography (PET) imaging because of its superior image quality and increasing access to PET radiotracers. New tracers on the horizon will also increase the image quality and flexibility of PET to accommodate exercise stress.”

 

The Future of 3-D Printing in Medicine

VIDEO: Applications in Cardiology for 3-D Printing and Computer-Aided Design

VIDEO: Better Flow Quantification and Rise of PET Among Trends in Cardiac Nuclear Imaging

Risk factors for osteoporosis and treatment adherence with osteoporosis medications

Posted on Updated on

According to New York-Presbyterian Hospital Endocrinology,” She has published widely in the medical literature and is co-editor of the book, The Bone and Mineral Manual.Dr. Siris served as the Medical Director of NORA, the National Osteoporosis Risk Assessment, a public health initiative and longitudinal study of osteoporosis that included over 200,000 postmenopausal women in the US. Most recently her research activity has focused both on risk factors for osteoporosis and treatment adherence with osteoporosis medications. Siris has been interviewed frequently on both television and radio and is often quoted in print media regarding osteoporosis.”

 

The Osteoporosis Manual: Prevention, Diagnosis, and Management

Ethel S. Siris, MD